Swift Ventures
-
Business & Markets · Startups Dash Bio Raises $30M in Series A Funding to Develop Automated Bioanalysis Platform for Drug Discovery
Insider Brief Dash Bio has raised $30 million in Series A funding to expand its automated bioanalysis laboratory and software platform, bringing its total capital raised to $47.5 million. Oak HC/FT led the round,… -
Business & Markets · Startups Dash Bio Secures $11 Million for Automated Bioanalysis and Drug Discovery
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.